Improved pregnancy outcomes in women exposed to malaria with high antibody levels against plasmodium falciparum

Journal of Infectious Diseases

Volumn 207, Issue 11, 2013, Pages 1664-1674

  Mayor, Alfredo ^a,c   Kumar, Urwashi ^d   Bardají, Azucena ^a,c   Gupta, Pankaj ^d   Jiménez, Alfons ^a,b   Hamad, Amel ^d   Sigaúque, Betuel ^c   Singh, Bijender ^d   Quintó, Llorenç ^a   Kumar, Sanjeev ^d   Gupta, Puneet K ^d   Chauhan, Virander S ^d   Dobaño, Carlota ^a,c   Alonso, Pedro L ^a,c   Menéndez, Clara ^a,c   Chitnis, Chetan E ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Ministérioda Saúde   (Mozambique)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

antibodies; falciparum; HIV; immune protection; malaria; pregnancy

Indexed keywords

DUFFY BINDING PROTEIN; IMMUNOGLOBULIN G; MATERNAL ANTIBODY; PARASITE ANTIGEN; PROTEIN AMA1; PROTEIN DBALPHA; PROTEIN DBL2X; PROTEIN DBL3X; PROTEIN DBL5EPSILON; PROTEIN DBL6EPSILON; PROTEIN EBA175; PROTEIN MSP1; UNCLASSIFIED DRUG; VAR2CSA ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA; MOZAMBIQUE; PARITY; PLACENTA DISORDER; PLACENTITIS; PLASMODIUM FALCIPARUM; PREGNANCY OUTCOME; PRIORITY JOURNAL; RESIDENTIAL AREA; SEASONAL VARIATION;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; YOUNG ADULT;

EID: 84877271841     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit083     Document Type: Article

References (48)

1. Brabin BJ, Romagosa C, Abdelgalil S, et al. The sick placenta-the role of malaria. Placenta 2004; 25:359-78.
2. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. Maternal antibodies block malaria. Nature 1998; 395:851-2.
3. Salanti A, Staalsoe T, Lavstsen T, et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 2003; 49:179-91.
4. Clausen TM, Christoffersen S, Dahlback M, et al. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria. J Biol Chem 2012; 287:23332-45.
5. Dahlback M, Nielsen MA, Salanti A. Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains? Trends Parasitol 2010; 26:230-5.
6. Srivastava A, Gangnard S, Round A, et al. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, highaffinity binding to CSA. Proc Natl Acad Sci USA 2010; 107:4884-9.
7. Fievet N, Le Hesran JY, Cottrell G, et al. Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy. Infect Genet Evol. 2006; 6:459-63.
8. Oleinikov AV, Rossnagle E, Francis S, Mutabingwa TK, Fried M, Duffy PE. Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens. J Infect Dis. 2007; 196:155-64.
9. Tutterrow YL, Avril M, Singh K, et al. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect Immun 2012; 80: 1479-90.
10. Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun 2003; 71:6620-3.
11. Salanti A, Dahlback M, Turner L, et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 2004; 200:1197-203.
12. Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 2004; 363:283-9.
13. Aitken EH, Mbewe B, Luntamo M, et al. Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment. J Infect Dis 2010; 201:1316-25.
14. Ataide R, Mwapasa V, Molyneux ME, Meshnick SR, Rogerson SJ. Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes. PLoS One 2011; 6:e22491.
15. Feng G, Aitken E, Yosaatmadja F, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. J Infect Dis 2009; 200:299-306.
16. Ataide R, HasangW, Wilson DW, et al. Using an improved phagocytosis assay to evaluate the effect of HIVon specific antibodies to pregnancyassociated malaria. PLoS One 2010; 5:e10807.
17. Cox SE, Staalsoe T, Arthur P, et al. Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent plasmodium falciparum isolates in Ghanaian primigravidae. Infect Immun 2005; 73:2841-7.
18. Serra-Casas E, Menendez C, Bardaji A, et al. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes. J Infect Dis 2009; 201:123-31.
19. Tuikue Ndam NG, Salanti A, Le-Hesran JY, et al. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of Senegalese pregnant women. J Infect Dis 2006; 193:713-20.
20. Megnekou R, Staalsoe T, Taylor DW, Leke R, Hviid L. Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens. Infect Immun 2005; 73:4112-8.
21. Beeson JG, Mann EJ, Elliott SR, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. J Infect Dis 2004; 189:540-51.
22. Maubert B, Fievet N, Tami G, Cot M, Boudin C, Deloron P. Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women. Infect Immun 1999; 67:5367-71.
23. Mayor A, Rovira-Vallbona E, Machevo S, et al. Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy. Infect Immun 2011; 79:1654-9.
24. Okoko BJ, Wesumperuma LH, Ota MO, et al. The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population. J Infect Dis 2001; 184:627-32.
25. Bousema T, Kreuels B, Gosling R. Adjusting for heterogeneity of malaria transmission in longitudinal studies. J Infect Dis 2011; 204:1-3.
26. Kinyanjui SM, Bejon P, Osier FH, Bull PC, Marsh K. What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity. Malar J 2009; 8:242.
27. Gonzalez R, Ataide R, Naniche D, Menendez C, Mayor A. HIV and malaria interactions: where do we stand? Expert Rev Anti Infect Ther 2012; 10:153-65.
28. Naniche D, Serra-Casas E, Bardaji A, et al. Reduction of antimalarial antibodies by HIV infection is associated with increased risk of Plasmodium falciparum cord blood infection. J Infect Dis 2012; 205:568-77.
29. ter Kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 2004; 71:41-54.
30. Saute F, Aponte J, Almeda J, et al. Malaria in southern Mozambique: malariometric indicators and malaria case definition in Manhica district. Trans R Soc Trop Med Hyg 2003; 97:661-6.
31. Menendez C, Bardaji A, Sigauque B, et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 2008; 3:e1934.
32. Alonso PL, Smith T, Schellenberg JR, et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1994; 344:1175-81.
33. Ordi J, Ismail MR, Ventura PJ, et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol 1998; 22:1006-11.
34. Mazumdar S, Sachdeva S, Chauhan VS, Yazdani SS. Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli. Bioprocess Biosyst Eng 2010; 33:719-30.
35. Pandey KC, Singh S, Pattnaik P, et al. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol Biochem Parasitol 2002; 123:23-33.
36. Kocken CH, Withers-Martinez C, Dubbeld MA, et al. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect Immun 2002; 70:4471-6.
37. Mayor A, Rovira-Vallbona E, Srivastava A, et al. Functional and immunological characterization of a Duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting. Infect Immun 2009; 77:3857-63.
38. Bir N, Yazdani SS, Avril M, Layez C, Gysin J, Chitnis CE. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria. Infect Immun 2006; 74:5955-63.
39. Osier FH, Fegan G, Polley SD, et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 2008; 76:2240-8.
40. Staalsoe T, Megnekou R, Fievet N, et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis 2001; 184:618-26.
41. Greenhouse B, Ho B, Hubbard A, et al. Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis 2011; 204:19-26.
42. Saute F, Aponte J, Almeda J, et al. Malaria in southern Mozambique: incidence of clinical malaria in children living in a rural community in Manhica district. Trans R Soc Trop Med Hyg 2003; 97:655-60.
43. Aitken EH, Mbewe B, Luntamo M, et al. Antibody to P. falciparum in pregnancy varies with intermittent preventive treatment regime and bed net use. PLoS One 2012; 7:e29874.
44. Pensieroso S, Cagigi A, Palma P, et al. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci USA 2009; 106:7939-44.
45. Titanji K, De Milito A, Cagigi A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006; 108:1580-7.
46. Fitzsimons D, Francois G, Hall A, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005; 23:4158-66.
47. Akpogheneta OJ, Duah NO, Tetteh KK, et al. Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun 2008; 76: 1748-55.
48. Nielsen MA, Pinto VV, Resende M, et al. Induction of adhesioninhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA. Infect Immun 2009; 77:2482-7.